Pulmonary Hypertension
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Imbalance of NFATc2 and KV1.5 Expression in Rat Pulmonary Vasculature of Nitrofen-Induced Congenital Diaphragmatic Hernia.
|
27522126 |
2017 |
Pulmonary Hypertension
|
0.500 |
Biomarker
|
phenotype |
RGD |
KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
|
20303989 |
2010 |
Paroxysmal atrial fibrillation
|
0.400 |
Biomarker
|
disease |
CTD_human |
Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
|
19698954 |
2010 |
Paroxysmal atrial fibrillation
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Atrial Fibrillation, Familial, 7
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Atrial Fibrillation, Familial, 7
|
0.400 |
Biomarker
|
disease |
CTD_human |
|
|
|
Atrial Fibrillation
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
SNX17 (Sorting Nexin 17) Mediates Atrial Fibrillation Onset Through Endocytic Trafficking of the Kv1.5 (Potassium Voltage-Gated Channel Subfamily A Member 5) Channel.
|
30939909 |
2019 |
Atrial Fibrillation
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
In addition, a positive correlation between the mRNA expression Cx40 and KCNA5 was observed in the atrial myocytes of patients with AF (P<0.05; r=0.42).
|
29201233 |
2017 |
Atrial Fibrillation
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Indeed, genetic variations of the atrial specific KCNA5 gene have been identified in patients with early-onset lone AF.
|
29034891 |
2017 |
Atrial Fibrillation
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
However, neither Kv1.5 protein nor KCNA5 mRNA had significant differences in adult and aged groups, non-RHD and RHD group, and men and women group of AF.
|
25918274 |
2015 |
Atrial Fibrillation
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
We hypothesized that early-onset lone AF is associated with high prevalence of genetic variants in KCNA5 and KCNAB2.
|
23264583 |
2013 |
Atrial Fibrillation
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Loss-of-function mutations in KCNA5 encoding the ultrarapid delayed rectifier potassium current I(Kur) have been identified in AF families.
|
20638934 |
2010 |
Atrial Fibrillation
|
0.390 |
Biomarker
|
disease |
CTD_human |
Recent studies, however, have shown that loss-of-function mutations in KCNA5, the gene that encodes K(V)1.5, the alpha subunit of the I(Kur) channel, is associated with the development of AF and that inhibition of I(Kur) can promote the induction of AF in experimental models.
|
19698954 |
2010 |
Atrial Fibrillation
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
These findings expand the spectrum of mutations in KCNA5 linked to AF and provide new insight into the molecular mechanism involved in AF.
|
19343045 |
2009 |
Atrial Fibrillation
|
0.390 |
GeneticVariation
|
disease |
LHGDN |
A pilot study to estimate the feasibility of assessing the relationships between polymorphisms in hKv1.5 and atrial fibrillation in patients following coronary artery bypass graft surgery.
|
18209767 |
2008 |
Atrial Fibrillation
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
This first report of Kv1.5 loss-of-function channelopathy establishes KCNA5 mutation as a novel risk factor for repolarization deficiency and atrial fibrillation.
|
16772329 |
2006 |
Idiopathic pulmonary arterial hypertension
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
5-HTT, BMPR2, EDN1, ENG, KCNA5 gene polymorphisms and susceptibility to pulmonary arterial hypertension: A meta-analysis.
|
30218748 |
2019 |
Idiopathic pulmonary arterial hypertension
|
0.360 |
Biomarker
|
disease |
BEFREE |
Decreased expression and inhibited activity of voltage-gated potassium channels, particularly KCNA5 (Kv1.5), are also seen in PAH, regardless of the cause, and facilitation of pulmonary arterial contraction and vascular remodeling has been shown.
|
27826710 |
2017 |
Idiopathic pulmonary arterial hypertension
|
0.360 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutation in BMPR2 Promoter: A 'Second Hit' for Manifestation of Pulmonary Arterial Hypertension?
|
26167679 |
2015 |
Idiopathic pulmonary arterial hypertension
|
0.360 |
Biomarker
|
disease |
BEFREE |
The aim of this study was to analyze the Bone Morphogenetic Protein Receptor 2 (BMPR2), Activin A type II receptor like kinase 1 (ALK1/ACVRL1) and potassium voltage-gated channel, shakerrelated subfamily, member 5 (KCNA5) genes in patients with idiopathic and associated PAH.
|
24936649 |
2014 |
Idiopathic pulmonary arterial hypertension
|
0.360 |
Biomarker
|
disease |
BEFREE |
Our data do not support an important role of KCNA5 as an SSc-susceptibility factor or as a PAH-development genetic marker for SSc patients.
|
23270786 |
2012 |
Idiopathic pulmonary arterial hypertension
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
We undertook this study to determine whether KCNA5 polymorphisms confer susceptibility to SSc and its vascular phenotype, including PAH.
|
20556823 |
2010 |
Idiopathic pulmonary arterial hypertension
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
|
17267549 |
2007 |
Malignant neoplasm of breast
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, following caveolin-1 knockdown, the expression of KCNA5 was decreased in MDA-MB-231 human breast cancer and MCF-10A-neoT non-tumorigenic epithelial cell lines.
|
30250548 |
2018 |
Idiopathic pulmonary hypertension
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutation in BMPR2 Promoter: A 'Second Hit' for Manifestation of Pulmonary Arterial Hypertension?
|
26167679 |
2015 |